Pemigatinib N-Ethyl Impurity - Request Quote
Pemigatinib N-Ethyl Impurity
| SZ CAT No: | SZ-P136006 |
| CAS No | NA |
| Mol.F. | C22H25F2N5O3 |
| Mol.Wt. | 445.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pemigatinib N-Ethyl Impurity is chemically 3-(2,6-Difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-((ethylamino)methyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one. Pemigatinib N-Ethyl Impurity is supplied with detailed characterization data compliant with regulatory guideline. Pemigatinib N-Ethyl Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pemigatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Pemigatinib N-Ethyl Impurity
Purchase Pemigatinib N-Ethyl Impurity
Pemigatinib N-Ethyl Impurity suppliers
Pemigatinib N-Ethyl Impurity manufacturers
Pemigatinib N-Ethyl Impurity price
Order Pemigatinib N-Ethyl Impurity
Enquire Pemigatinib N-Ethyl Impurity
Pemigatinib N-Ethyl Impurity cost
Pemigatinib N-Ethyl Impurity Supplier
Pemigatinib N-Ethyl Impurity Distributor
Pemigatinib N-Ethyl Impurity for Method Validation
Pemigatinib Reference Standard
Pemigatinib N-Ethyl Impurity for ANDA Filing
Pemigatinib N-Ethyl Impurity for Forced Degradation Studies
Pemigatinib N-Ethyl Impurity Identification Standards
Pemigatinib N-Ethyl Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.